TCIM
MRNS

TIAA CREF Investment Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

TIAA CREF Investment Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.1M Buy
65,839
+28,364
+76% +$408K ﹤0.01% 2275
2018
Q4 		$430K Sell
37,475
-356
-0.9% -$7.2K ﹤0.01% 2635
2018
Q3 		$1.51M Sell
37,831
-19,082
-34% -$543K ﹤0.01% 2257
2018
Q2 		$1.61M Buy
+56,913
New +$1.26M ﹤0.01% 2286

Other funds holding MRNS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

TIAA CREF Investment Management's MRNS Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Marinus Pharmaceuticals, Inc (MRNS) stake by 76% in Q1 2019, buying an estimated $408K and bringing the position to 65,839 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2275.

TIAA CREF Investment Management first reported a position in MRNS in Q2 2018 and has held it in 4 quarters since. The position peaked at $1.61M in Q2 2018. 81 funds tracked by Wall St. Rank hold MRNS as of Q1 2019.

  • TIAA CREF Investment Management held 65,839 shares of Marinus Pharmaceuticals, Inc worth $1.1M as of Q1 2019.
  • TIAA CREF Investment Management bought 28,364 Marinus Pharmaceuticals, Inc shares in Q1 2019, an estimated $408K.
  • Marinus Pharmaceuticals, Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2275 holding.
  • TIAA CREF Investment Management first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's Marinus Pharmaceuticals, Inc position peaked at $1.61M in Q2 2018.
  • 81 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.